• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INSTITUT STRAUMANN AG SP,Ø4.8MM RN, SLACT.12MM,ROXOLID,GUIDED; ENDOSSEOUS DENTAL IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INSTITUT STRAUMANN AG SP,Ø4.8MM RN, SLACT.12MM,ROXOLID,GUIDED; ENDOSSEOUS DENTAL IMPLANT Back to Search Results
Catalog Number 033.593G
Medical Device Problem Code Loss of Osseointegration (2408)
Health Effect - Clinical Codes Hypersensitivity/Allergic reaction (1907); Inflammation (1932); Swelling/ Edema (4577)
Date of Event 04/23/2023
Type of Reportable Event Serious Injury
Event or Problem Description
The clinician reports the implant was inserted (b)(6) 2016, in fdi 46.On (b)(6) 2023, loss of osseointegration was verified.The device was forwarded to the manufacturer.At the event the patient experienced: swelling, hypersensitivity and inflammation.No further patient complications were reported.
 
Additional Manufacturer Narrative
The batch number could be verified.Our manufacturing q-system assures, that production and process controls are in place to ensure that batches confirm to the applicable specifications before they are distributed.  the loss of an endosseous dental implant after successful osseointegration and restoration is a known inherent risk of the procedure.Implants may have to be removed in case one or more of the implant success criteria are not met.Implant success criteria according to buser et al.(1991) are: 1.Absence of persistent subjective complaints such as pain, foreign body sensation and /or dysesthesia.2.Absence of a recurrent peri-implant infection with suppuration.3.Absence of implant mobility.4.Absence of a continuous radiolucency around the implant.The manufacturer's trend analysis confirms that the reported failure rate associated with its dental implants is below the expected failure rate for this treatment as published in the scientific literature.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SP,Ø4.8MM RN, SLACT.12MM,ROXOLID,GUIDED
Common Device Name
ENDOSSEOUS DENTAL IMPLANT
Manufacturer (Section D)
INSTITUT STRAUMANN AG
peter merian-weg 12
basel 04002
SZ  04002
Manufacturer (Section G)
INSTITUT STRAUMANN AG
peter merian-weg 12
basel 04002
SZ   04002
Manufacturer Contact
jennifer jackson
60 minuteman road
andover, MA 01810
9787472509
MDR Report Key17879119
Report Number0009613348-2023-111897
Device Sequence Number15308041
Product Code DZE
UDI-Device Identifier07630031716170
UDI-Public07630031716170
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
K122855
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Device Explanted Year2023
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Dentist
Type of Report Initial
Report Date (Section B) 10/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date05/12/2019
Device Catalogue Number033.593G
Device Lot NumberHC092
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/11/2023
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date10/05/2023
Event Location Other
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date10/05/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/12/2014
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age49 YR
Patient SexMale
-
-